Scientists Discover Gene Mutation That Signals Aggressive Melanoma

Translate to Spanish or other 102 languages!

Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report. Image for illustration purposes
Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report. Image for illustration purposes

Mega Doctor News

- Advertisement -

by Mount Sinai Health System


Newswise — New York, NY – Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report.

The findings suggest that patients whose melanoma tumors have an ARID2 mutation may have a more aggressive cancer and may need to be treated differently, according to a study published in Cell Reports in April.

- Advertisement -

“Our study is the first to characterize the tumor-suppressive functions of ARID2 in melanoma,” said the study’s lead author Emily Bernstein, PhD, Professor of Oncological Sciences at The Tisch Cancer Institute at Mount Sinai. “We modeled ARID2 mutations by removing the ARID2 protein completely from melanoma cells and studied the consequences in the petri dish and in animal models. Recreating actual mutations that patients harbor is challenging, but now possible by genome editing, and would further provide a more accurate model; such studies are ongoing in the lab.”

Melanoma is the deadliest form of skin cancer, and develops in the cells that produce melanin, the pigment that gives people’s skin its color. While melanoma can be treated successfully when caught early, it can also be quite aggressive and spread from tumors as small as a couple millimeters to vital organs like the brain. Understanding metastatic melanoma is essential to save lives from this disease, which affects 200,000 people a year worldwide.

ARID2 is part of a chromatin remodeling complex and frequently mutated in melanoma. In this study, scientists used melanoma tumor models to measure the role of the ARID2 gene in cancer progression. They assessed the effects of ARID2 loss on the epigenetic landscape, a dynamic DNA and protein platform that They found that without ARID2, melanoma cells exhibit increased metastatic behaviors.Researchers from New York University and Purdue University contributed greatly to this research. This study was funded by the National Cancer Institute, American Skin Association, and National Cancer Center

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AI-Powered Blood Test Successfully Detects Liver Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

STC Names Nurse Educator Teena Jacob 2026 Faculty of the Year

For South Texas College faculty member Teena Jacob, DNP, teaching is another form of caregiving. She approaches her students with the same compassion, patience and attentiveness that have defined her career as a nurse, helping them grow into confident, skilled healthcare professionals.

Updated Level IV Trauma Center Standards Announced by ACS

The American College of Surgeons Committee on Trauma (ACS COT) has released new standards for Level IV trauma centers. The new resource, Resources for Optimal Care of the Injured Patient: Level IV Trauma Center Standards (2026), can help Level IV trauma centers assess capabilities, identify improvement opportunities, and strengthen trauma care delivery. 

Not Just Arthritis: 3 Common Hip Conditions That May Require Replacement

A Yale review published in EFORT Open Reviews describes three different but overlapping causes of non-arthritic hip pain.
- Advertisement -